Blue Jet Healthcare Ltd. will host an earnings call on Tuesday, July 22, 2025, at 5:00 PM (IST) to discuss the financial results for the quarter ended June 30, 2025. The company is a global, science-led pharmaceutical company specializing in pharmaceutical intermediates and APIs.
The earnings conference call will be accessible via universal access numbers +91 22 6280 1107 and +91 22 7115 8008. International toll-free numbers are also available for the USA (18667462133), UK (08081011573), Singapore (8001012045), and Hong Kong (800964448). Participants can also join via Diamond Pass for quicker access.
The management representation for the call will include Mr. Shiven Arora (Managing Director), Mr. V.K. Singh (Chief Operating Officer), Mr. Ganesh Karuppannan (Chief Financial Officer), and Mr. Sanjay Sinha (Deputy Chief Financial Officer).
Blue Jet Healthcare operates under a contract development and manufacturing organization (CDMO) business model, with specialized chemistry capabilities in contrast media intermediates and high-intensity sweeteners. The company supplies critical starting intermediates and advanced intermediates to major contrast media manufacturers, including GE Healthcare, Guerbet, and Bracco, and high-intensity sweeteners to multi-national companies like Colgate Palmolive (India) Limited and Unilever.
